Scarica l'app Stockscreener
1.18
0.00%
0.00
Pre-mercato:
1.18
Mira Pharmaceuticals Inc Borsa (MIRA) Ultime notizie
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 6.6%Time to Sell? - MarketBeat
MIRA Pharmaceuticals (NASDAQ:MIRA) Stock Price Down 6.6%Time to Sell? - MarketBeat
Bear Alert: How is GIGGW managing supply chain issues2025 Big Picture & Long Hold Capital Preservation Plans - baoquankhu1.vn
MIRA Pharmaceuticals initiates final dosing in phase 1 trial of Ketamir-2 - Investing.com Nigeria
MIRA Pharmaceuticals initiates final dosing in phase 1 trial of Ketamir-2 By Investing.com - Investing.com South Africa
MIRA Pharmaceuticals Initiates Final Cohort of Ketamir-2 Phase 1 Clinical Study as Company Prepares for Phase 2a Study - Weatherford Democrat
Cancer nerve pain has no approved drugs. Oral trial nears first-phase finish - Stock Titan
MIRA Pharmaceuticals Advances Ketamir-2 Phase 1 to Final Cohort - TipRanks
MIRA Pharmaceuticals Announces Favorable Topline Results from Phase 1 SAD Study of Oral Ketamir-2, a Next-Generation Non-Scheduled Ketamine Analog - Pensacola News Journal
Value Recap: What is the Moat Score of MIRA Pharmaceuticals IncWeekly Trade Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Fundamentals Check: What is AVGOs revenue forecastMarket Sentiment Summary & Reliable Price Breakout Signals - baoquankhu1.vn
Can MIRA Pharmaceuticals Inc. stock deliver consistent earnings growthGlobal Markets & Safe Entry Zone Identification - bollywoodhelpline.com
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Sees Significant Growth in Short Interest - Defense World
Nasdaq Moves: Is DiaMedica Therapeutics Inc a cyclical or defensive stockMarket Performance Summary & Expert Verified Movement Alerts - baoquankhu1.vn
Aug Big Picture: How does MIRA Pharmaceuticals Inc compare to its peersGap Down & Detailed Earnings Play Strategies - baoquankhu1.vn
Will MIRA Pharmaceuticals Inc. stock maintain dividend yieldWide Width Options & HOKA model picks for your routine - Улправда
Trendlines Suggest Garment Mantra Lifestyle Limited May Bottom Out Soon - Bollywood Helpline
2026 world cup usa national team qualification midfield leaders build up play winner prediction guideJuly 2025 Volume & Low Volatility Stock Recommendations - Улправда
2026 world cup mexico qualification playmakers low block knockout prediction analysis - Улправда
2026 world cup canada qualification match preview insightsIndex Update & Fast Entry and Exit Trade Plans - Улправда
MIRA Pharmaceuticals Inc. (MIRA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Quarterly Risk: Will MIRA Pharmaceuticals Inc stock gain from strong economyJobs Report & Real-Time Buy Signal Alerts - Bộ Nội Vụ
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Update - MarketBeat
Resistance Break Could Fuel Unichem Laboratories Limited RallyEarnings Beat Highlights & Maximize Gains Professionally - Bollywood Helpline
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus By Investing.com - Investing.com South Africa
Mira Pharmaceuticals approves CEO incentive awards including SKNY acquisition bonus - Investing.com
Will MIRA Pharmaceuticals Inc. stock gain from strong economyJuly 2025 Recap & Fast Moving Stock Trade Plans - Bölüm Sonu Canavarı
Is MIRA Pharmaceuticals Inc. stock a safe investment in uncertain markets2025 Price Targets & Fast Entry Momentum Trade Alerts - Улправда
MIRA Pharmaceuticals (MIRA) details 2025 CEO bonuses and equity awards - Stock Titan
Can MIRA Pharmaceuticals Inc. stock beat analyst upgradesOptions Play & Weekly Setup with ROI Potential - Улправда
Is MIRA Pharmaceuticals Inc. stock attractive for growth ETFsMarket Performance Recap & Technical Pattern Alert System - Улправда
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1% – Here’s What Happened - Defense World
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Up 2.1%Here's What Happened - MarketBeat
MIRA Pharmaceuticals expands stock offering by $15M - MSN
Mira Pharmaceuticals increases at-the-market offering by $15.2 million - Investing.com Canada
MIRA Pharmaceuticals Expands Stock Offering by $15M - TipRanks
MIRA Pharmaceuticals Increases Stock Offering Limit - TradingView — Track All Markets
Mira Pharmaceuticals (MIRA) Stock Analysis Report | Financials & Insights - Benzinga
How MIRA Pharmaceuticals Inc. stock performs in rising dollar environmentTrade Ideas & Verified Technical Signals - Newser
Why MIRA Pharmaceuticals Inc. stock is seen as undervaluedJuly 2025 Review & Daily Technical Forecast Reports - Newser
Is MIRA Pharmaceuticals Inc. stock attractive for passive investorsTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Why MIRA Pharmaceuticals Inc. stock remains on watchlistsAnalyst Upgrade & Scalable Portfolio Growth Methods - Newser
MIRA Pharmaceuticals (NASDAQ:MIRA) and Annovis Bio (NYSE:ANVS) Critical Analysis - Defense World
Telomir and Mira Pharmaceuticals advance through key development milestones with Recipharm support - marketscreener.com
0.94%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):